AERIE PHARMACEUTICALS INC (AERI) is a publicly traded company in the Unknown sector. Across all available filings, 39 corporate insiders have executed 389 transactions totaling $260.7M, demonstrating a bearish sentiment with -$184.6M in net insider flow. The most recent transaction on Nov 21, 2022 involved a transaction of 215,783 shares valued at $3.3M.
No significant insider buying has been recorded for AERI in the recent period.
No significant insider selling has been recorded for AERI in the recent period.
Based on recent SEC filings, insider sentiment for AERI is bearish with an Insider Alignment Score of 15/100 and a net flow of -$184.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AERIE PHARMACEUTICALS INC (AERI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 39 insiders are actively trading AERI stock, having executed 389 transactions in the past 90 days. The most active insider is Anand Mehra (Executive), who has made 13 transactions totaling $63.0M.
Get notified when executives and directors at AERI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Kannan Raj | Executive | Disposition | 215,783 | $15.25 | $3.3M | Large |
| Nov 21, 2022 | Calabrese Jeffrey | Executive | Disposition | 18,585 | $15.25 | $283.4K | |
| Nov 21, 2022 | Croarkin Richard | Executive | Disposition | 16,095 | $15.25 | $245.4K | |
| Nov 21, 2022 | Michael Du Toit | Executive | Disposition | 16,095 | $15.25 | $245.4K | |
| Nov 21, 2022 | W. Gryska David | Executive | Disposition | 1,996 | $15.25 | $30.4K | |
| Nov 21, 2022 | W. Gryska David | Executive | Disposition | 11,495 | $15.25 | $175.3K | |
| Nov 21, 2022 | Larocca John | Executive | Disposition | 53,585 | $15.25 | $817.2K | Large |
| Nov 21, 2022 | Frederick Lang Peter | Executive | Disposition | 46,297 | $15.25 | $706.0K | Large |
| Nov 21, 2022 | C. Kopczynski Casey | Executive | Disposition | 280,244 | $15.25 | $4.3M | Large |
| Nov 21, 2022 | J. Mcdonnell Peter | Executive | Disposition | 7,995 | $15.25 | $121.9K | |
| Nov 21, 2022 | F. Mcgraw Benjamin III | Executive | Disposition | 41,984 | $15.25 | $640.3K | Large |
| Nov 21, 2022 | Mchugh Julie | Executive | Disposition | 16,095 | $15.25 | $245.4K | |
| Nov 1, 2022 | Calabrese Jeffrey | Executive | Payment | 179 | $15.22 | $2.7K | |
| Aug 14, 2022 | Calabrese Jeffrey | Executive | Payment | 265 | $11.57 | $3.1K | |
| Aug 14, 2022 | Larocca John | Executive | Payment | 771 | $11.57 | $8.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 67 | $222.7M | 78.8% |
Purchase(P) | 45 | $38.1M | 13.5% |
Disposition(D) | 12 | $11.1M | 3.9% |
Payment(F) | 121 | $4.7M | 1.6% |
Exercise (Options)(X) | 7 | $3.8M | 1.3% |
Exercise(M) | 17 | $2.1M | 0.8% |
Other(J) | 6 | $110.3K | 0.0% |
Conversion(C) | 13 | $17.0K | 0.0% |
Award(A) | 99 | $0 | 0.0% |
Will Acquisition(W) | 2 | $0 | 0.0% |
Insider selling pressure at AERIE PHARMACEUTICALS INC has increased, with 39 insiders executing 389 transactions across all time. Total sales of $222.7M significantly outpace purchases of $38.1M, resulting in a net outflow of $184.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.